121 related articles for article (PubMed ID: 5314973)
1. [Reproducible, irreversible hemorrhagic shock in rabbits with determination of survival rate. Initial therapeutic experiments with adenosine triphosphate, potassium-magnesium aspartate and the proteinase inhibitor trasylol].
Hess A; Ringeling M; Schering J; Schmitt W; Steyer M; Willebrand J; Scheibe O
Chirurg; 1971 Jul; 42(7):317-20. PubMed ID: 5314973
[No Abstract] [Full Text] [Related]
2. The effects of ATP and a proteolytic enzyme inhibitor in irreversible shock.
Massion WH; Erdos EG
J Okla State Med Assoc; 1966 Aug; 59(8):467-71. PubMed ID: 5296339
[No Abstract] [Full Text] [Related]
3. "The effect of ATP on survival in intestinal ischemia shock, hemorrhagic shock, and endotoxin shock in rats".
Chaudry IH
Circ Shock; 1982; 9(6):629-31. PubMed ID: 6983934
[No Abstract] [Full Text] [Related]
4. [Action of small doses of sodium aspartate on the evolution of hemorrhagic shock in rabbits].
Laborit H; Baron C; Olympie J; Laborit G
Agressologie; 1973; 14(2):93-7. PubMed ID: 4776378
[No Abstract] [Full Text] [Related]
5. Effect of adenosine triphosphate-magnesium chloride administration in shock.
Chaudry IH; Sayeed MM; Baue AE
Surgery; 1974 Feb; 75(2):220-7. PubMed ID: 4812045
[No Abstract] [Full Text] [Related]
6. [Administration of ATP for the treatment of hemorrhagic shock].
Sumida S
Masui; 1970 Apr; 19(4):387-402. PubMed ID: 5464952
[No Abstract] [Full Text] [Related]
7. [Hemorrhagic shock and proteinase inhibitor. Experimental analysis of the effects of this therapy on the ultrastructural lesions of the shock liver].
Mallet-Guy Y; Switalska C; Botev S; Mallet-Guy P
J Chir (Paris); 1971 Apr; 101(4):361-76. PubMed ID: 5314385
[No Abstract] [Full Text] [Related]
8. The effect of ATP on survival in intestinal ischemia shock, hemorrhagic shock, and endotoxin shock in rats.
Van der Meer C; Snijders PM; Valkenburg PW
Circ Shock; 1982; 9(6):619-28. PubMed ID: 6983933
[TBL] [Abstract][Full Text] [Related]
9. [Proteinase inhibitor and the liver in shock. Experimental and ultrastructural study].
Mallet-Guy P; Mallet-Guy Y; Switalska C; Botev S
Bull Soc Int Chir; 1972; 31(5):473-80. PubMed ID: 4540273
[No Abstract] [Full Text] [Related]
10. The absence of benefit of proteinase inhibition with aprotinin in severe shock in dogs.
Smith JA; Norman JN
Resuscitation; 1978; 6(4):249-58. PubMed ID: 314652
[TBL] [Abstract][Full Text] [Related]
11. [Movicard from the viewpoint of the rural practitioner].
Schroedinger L
Z Allgemeinmed; 1969 Sep; 45(25):1180-1. PubMed ID: 5362235
[No Abstract] [Full Text] [Related]
12. [Trasylol in the shock therapy. Its effects and their interpretation].
Haberland GL; Koslowski L; Matis P
Med Welt; 1972 Aug; 23(31):1049-56. PubMed ID: 4539608
[No Abstract] [Full Text] [Related]
13. Effect of magnesium L-aspartate on the platelet function of thrombocytasthenia.
Hyodo S; Shirakawa M; Aso T
Isr J Med Sci; 1965 Jul; 1(4):860-1. PubMed ID: 5856134
[No Abstract] [Full Text] [Related]
14. [Treatment of experimental hemorrhagic shock with a protease inhibitor: aprotinin].
Serrano JJ; Uccelli G; Liutkus M; Boucard M
Therapie; 1979; 34(1):103-110. PubMed ID: 314684
[No Abstract] [Full Text] [Related]
15. [Definitive survival after experimental irreversible hemorrhagic shock. Roles of metabolic correction and oral treatment by neomycin. Development of acid phosphatases].
Laborit H; Baron C; Weber B
Agressologie; 1967; 8(2):143-8. PubMed ID: 5602122
[No Abstract] [Full Text] [Related]
16. [Effect of potassium and magnesium aspartate on experimental myocardial ischemia and infarction].
Jiang XR; Chen WP; Shi HL; Zhou LF
Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):36-9. PubMed ID: 6232818
[No Abstract] [Full Text] [Related]
17. Effects of 2-[(5-chloro-2-methoxyphenyl)azo]-1H-imidazole (M6434) on hemorrhagic, cardiogenic, and endotoxin shock in rats and rabbits.
Ohnishi H; Yamaguchi K; Sato M; Uemura A; Funato H; Dabasaki T
Circ Shock; 1984; 13(3):261-70. PubMed ID: 6467523
[TBL] [Abstract][Full Text] [Related]
18. High-dose glucose-insulin-potassium in treatment of irreversible hemorrhagic shock.
Whitten RH; Egdahl RH
Surg Forum; 1976; 27(62):60-2. PubMed ID: 1019992
[No Abstract] [Full Text] [Related]
19. Hemodynamic effects of ATP-MgCl2 following shock.
McGovern PJ; Machiedo GW; Rush BF
Curr Surg; 1982; 39(2):82-4. PubMed ID: 7083900
[No Abstract] [Full Text] [Related]
20. Preparation of ATP-MgCl2 and precautions for its use in the study and treatment of shock and ischemia.
Chaudry IH
Am J Physiol; 1982 May; 242(5):R604-5. PubMed ID: 7081483
[No Abstract] [Full Text] [Related]
[Next] [New Search]
